- MOA
- Antiplatelet
- Converted to active metabolite then
- Binds P2Y12 receptor on platelet to prevent ADP binding
- Selective irreversible antagonist of P2Y12 receptor (platelets)
- Dose
- 75mg OD
- Considerations
- No antidote
- Perioperative Management
- Withhold 5 days prior to surgery